ARTICLE | Company News
Teva sales and marketing update
December 11, 2000 8:00 AM UTC
TEVA and partner Aventis S.A. (AVE, Strasbourg, France) began U.K. sales of Copaxone glatiramer acetate to reduce the frequency of relapses in relapsing-remitting multiple sclerosis. ...